Educational Objectives

Following this program, participants should be able to:

• Discuss updates to NCCN guidelines for breast, colon, kidney, non-small cell lung, prostate, and rectal cancers, chronic myelogenous leukemia, hepatocellular carcinoma, mycosis fungoides/Sézary Syndrome, multiple myeloma, and non-Hodgkin’s lymphoma.
• Identify preferred methods for toxicity management.
• Recognize clinical issues surrounding the use of growth factors
• Report advances in the treatment of small cell lung cancer
• Explain the innovative mechanisms of action found in combination therapy
• Describe the issues involved in sequencing drugs for metastatic renal cell carcinoma
• Demonstrate the usefulness of new imaging techniques in managing solid tumors and lymphomas
• Summarize the latest trends in predictive medicine
• Discuss the findings of the NCCN Task Force for: Breast Cancer in the Older Woman; mTOR Inhibition in Solid Tumors; Prevention and Management of Mucositis in Cancer Care; and Oral Chemotherapy

These objectives are subject to change as agenda is finalized.

Last Update: 12/10/2007